Trinity biotech announces additional funding to support transformation plan & continued development of the company's continuous glucose monitoring technology

Dublin, ireland, feb. 28, 2025 (globe newswire) -- trinity biotech plc (nasdaq: trib), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has obtained an additional $4m in debt financing from its primary lender, perceptive advisors.
TRIB Ratings Summary
TRIB Quant Ranking